| |
| |
NEW ON THE MARKET
|
| |
New drug for gout: febuxostat (ADENURIC)
Prucalopride (RESOLOR) for chronic obstipation
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
| |
Bipolar disorder: lithium plus valproic acid?
Cave: Tamoxifen plus CYP 2D6 inhibitors
|
| |
| |
READERS' QUESTIONS AND COMMENTS
|
| |
Pink rockrose extract CYSTUS 052 against influenza?
XENOBILOX: price rise by a factor of 15
|
| |
| |
IN BRIEF
|
| |
Ethosuximide (e.g. PETNIDAN) in childhood absence epilepsy
No primary prevention with acetylsalicylic acid
Intensive care: dopamine or noradrenaline for treatment of shock?
Losartan (LORZAAR) generics available
Denture adhesive COREGA ULTRA off market
Trade names likely to be mistaken
|
| |
| |
CURRENT ADR NETWORK REPORT
|
 |
Nose bleeds due to alpha receptor blocker tamsulosin
|
| |
| |
SIDE EFFECTS
|
| |
Bradycardia due to antihistamine fexofenadine
|
| |